Holen Sie sich die Stockscreener-App
2.29
1.29%
-0.03
Handel nachbörslich:
2.29
Schlusskurs vom Vortag:
$2.32
Offen:
$2.311
24-Stunden-Volumen:
17,268
Relative Volume:
0.24
Marktkapitalisierung:
$93.90M
Einnahmen:
$2.70M
Nettoeinkommen (Verlust:
$5.53M
KGV:
20.82
EPS:
0.11
Netto-Cashflow:
$-10.55M
1W Leistung:
-0.87%
1M Leistung:
+10.10%
6M Leistung:
-4.18%
1J Leistung:
-7.66%
1-Tages-Spanne:
$2.27
$2.3236
1-Wochen-Bereich:
$2.2655
$2.45
52-Wochen-Spanne:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Firmenname
Oramed Pharmaceuticals Inc
Sektor
Branche
Telefon
646-844-1164
Adresse
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Vergleichen Sie ORMP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.29 | 95.13M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-12 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-02-09 | Eingeleitet | National Securities | Buy |
| 2020-12-03 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-03-11 | Eingeleitet | Aegis Capital | Buy |
| 2019-09-11 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-12-11 | Fortgesetzt | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | Bestätigt | FBR Capital | Outperform |
| 2015-12-01 | Bestätigt | H.C. Wainwright | Buy |
| 2015-11-19 | Eingeleitet | FBR Capital | Outperform |
| 2015-04-13 | Fortgesetzt | MLV & Co | Buy |
| 2014-01-30 | Bestätigt | Aegis Capital | Buy |
| 2014-01-08 | Bestätigt | Aegis Capital | Buy |
| 2014-01-08 | Eingeleitet | MLV & Co | Buy |
| 2013-12-03 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Oramed Pharmaceuticals Inc Aktie (ORMP) Neueste Nachrichten
Does Oramed Pharmaceuticals Inc. stock reflect fundamentals2025 Earnings Impact & Real-Time Chart Pattern Alerts - خودرو بانک
Panic Selling: Is Oramed Pharmaceuticals Inc a top pick in the sectorJuly 2025 Fed Impact & Precise Entry and Exit Recommendations - خودرو بانک
Rally Mode: Can Bellevue Life Sciences Acquisition Corp Equity Right scale operations efficiently - خودرو بانک
What Fibonacci levels say about Oramed Pharmaceuticals Inc. reboundMarket Growth Review & Low Drawdown Investment Ideas - newser.com
Market Overview: How sensitive is Oramed Pharmaceuticals Inc to inflationJuly 2025 Earnings & Safe Investment Capital Preservation Plans - خودرو بانک
Market Recap: What is Oramed Pharmaceuticals Incs 5 year growth outlookExit Point & Real-Time Volume Analysis Alerts - خودرو بانک
Will Oramed Pharmaceuticals Inc. stock go up soonJuly 2025 Highlights & Risk Controlled Stock Alerts - newser.com
Aug Technicals: Can Oramed Pharmaceuticals Inc navigate macro headwindsJuly 2025 Setups & Long-Term Safe Investment Plans - خودرو بانک
Stock Recap: Is Oramed Pharmaceuticals Inc stock good for income investorsJuly 2025 Price Swings & Stepwise Trade Signal Guides - خودرو بانک
What moving averages say about Oramed Pharmaceuticals Inc.Earnings Risk Report & AI Driven Stock Reports - newser.com
EV Market: Does FUBO have consistent dividend growthGap Up & Weekly Sector Rotation Insights - خودرو بانک
Regression analysis insights on Oramed Pharmaceuticals Inc. performanceJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - newser.com
Market reaction to Oramed Pharmaceuticals Inc.’s recent newsMarket Sentiment Summary & AI Optimized Trading Strategy Guides - newser.com
How to read the order book for Oramed Pharmaceuticals Inc.Take Profit & Long-Term Capital Growth Strategies - newser.com
How to forecast Oramed Pharmaceuticals Inc. trends using time seriesPrice Action & Risk Controlled Daily Trade Plans - newser.com
What the charts say about Oramed Pharmaceuticals Inc. todayJuly 2025 Spike Watch & Low Volatility Stock Recommendations - newser.com
Tools to monitor Oramed Pharmaceuticals Inc. recovery probabilityPortfolio Gains Report & Risk Controlled Daily Plans - newser.com
How to recover losses in Oramed Pharmaceuticals Inc. stockPortfolio Profit Report & Reliable Price Breakout Alerts - Newser
How moving averages guide Oramed Pharmaceuticals Inc. tradingJuly 2025 Catalysts & Community Trade Idea Sharing Platform - Newser
Chart based exit strategy for Oramed Pharmaceuticals Inc.Portfolio Value Summary & Accurate Buy Signal Alerts - Newser
Is Oramed Pharmaceuticals Inc. forming a bottoming baseWeekly Stock Summary & Smart Swing Trading Techniques - Newser
How to integrate Oramed Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 Trade Ideas & Capital Efficient Trading Techniques - Newser
Oramed Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Spike Watch & Growth Focused Stock Reports - Newser
Will Oramed Pharmaceuticals Inc. continue its uptrendEarnings Recap Report & Low Risk High Win Rate Stock Picks - Newser
Advanced analytics toolkit walkthrough for Oramed Pharmaceuticals Inc.Portfolio Update Summary & Stepwise Entry/Exit Trade Alerts - Newser
Should you hold or exit Oramed Pharmaceuticals Inc. nowBear Alert & Accurate Buy Signal Notifications - Newser
Earnings visualization tools for Oramed Pharmaceuticals Inc.Analyst Downgrade & Daily Price Action Insights - Newser
Historical volatility pattern of Oramed Pharmaceuticals Inc. visualizedEarnings Summary Report & Free AI Powered Buy and Sell Recommendations - Newser
Is Oramed Pharmaceuticals Inc. still worth holding after the dip2025 Risk Factors & AI Powered Market Entry Strategies - Newser
Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Price Crosses Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Can Oramed Pharmaceuticals Inc. recover in the next quarterJuly 2025 Short Interest & Long-Term Growth Plans - Newser
What MACD and RSI say about Oramed Pharmaceuticals Inc.2025 Institutional Moves & Short-Term Trading Alerts - Newser
What indicators show strength in Oramed Pharmaceuticals Inc.July 2025 Market Mood & Momentum Based Trading Ideas - Newser
Evaluating Oramed Pharmaceuticals Inc. with trendline analysis2025 Big Picture & Safe Entry Momentum Tips - Newser
Detecting price anomalies in Oramed Pharmaceuticals Inc. with AIPortfolio Profit Report & Real-Time Buy Zone Alerts - Newser
What makes Oramed Pharmaceuticals Inc. stock price move sharplyMarket Volume Report & Risk Adjusted Swing Trade Ideas - Newser
Identifying reversal signals in Oramed Pharmaceuticals Inc.Treasury Yields & Safe Capital Growth Tips - Newser
Can volume confirm reversal in Oramed Pharmaceuticals Inc.Inflation Watch & Consistent Return Investment Signals - Newser
Building trade automation scripts for Oramed Pharmaceuticals Inc.July 2025 WrapUp & Verified Chart Pattern Trade Signals - Newser
Published on: 2025-09-09 17:48:00 - Newser
Finanzdaten der Oramed Pharmaceuticals Inc-Aktie (ORMP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.77%
1.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):